To probe the human B cell repertoire for SARS-CoV-2-protective B cells from pre-immune individuals in order to guide vaccine and monoclonal antibody design against COVID-19.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Jim BoonyaratanakornkitResearch Location
United States of AmericaLead Research Institution
Fred Hutchinson Cancer Research CenterResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
ImmunitySpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
To probe the human B cell repertoire for SARS-CoV-2-protective B cells from pre-immune individuals in order to guide vaccine and monoclonal antibody design against COVID-19.